Cargando…

An autoinhibited state of 53BP1 revealed by small molecule antagonists and protein engineering

The recruitment of 53BP1 to chromatin, mediated by its recognition of histone H4 dimethylated at lysine 20 (H4K20me2), is important for DNA double-strand break repair. Using a series of small molecule antagonists, we demonstrate a conformational equilibrium between an open and a pre-existing lowly p...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Gaofeng, Botuyan, Maria Victoria, Drané, Pascal, Hu, Qi, Bragantini, Benoît, Thompson, James R., Schuller, David J., Detappe, Alexandre, Perfetti, Michael T., James, Lindsey I., Frye, Stephen V., Chowdhury, Dipanjan, Mer, Georges
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10541411/
https://www.ncbi.nlm.nih.gov/pubmed/37773238
http://dx.doi.org/10.1038/s41467-023-41821-6
_version_ 1785113899772674048
author Cui, Gaofeng
Botuyan, Maria Victoria
Drané, Pascal
Hu, Qi
Bragantini, Benoît
Thompson, James R.
Schuller, David J.
Detappe, Alexandre
Perfetti, Michael T.
James, Lindsey I.
Frye, Stephen V.
Chowdhury, Dipanjan
Mer, Georges
author_facet Cui, Gaofeng
Botuyan, Maria Victoria
Drané, Pascal
Hu, Qi
Bragantini, Benoît
Thompson, James R.
Schuller, David J.
Detappe, Alexandre
Perfetti, Michael T.
James, Lindsey I.
Frye, Stephen V.
Chowdhury, Dipanjan
Mer, Georges
author_sort Cui, Gaofeng
collection PubMed
description The recruitment of 53BP1 to chromatin, mediated by its recognition of histone H4 dimethylated at lysine 20 (H4K20me2), is important for DNA double-strand break repair. Using a series of small molecule antagonists, we demonstrate a conformational equilibrium between an open and a pre-existing lowly populated closed state of 53BP1 in which the H4K20me2 binding surface is buried at the interface between two interacting 53BP1 molecules. In cells, these antagonists inhibit the chromatin recruitment of wild type 53BP1, but do not affect 53BP1 variants unable to access the closed conformation despite preservation of the H4K20me2 binding site. Thus, this inhibition operates by shifting the conformational equilibrium toward the closed state. Our work therefore identifies an auto-associated form of 53BP1—autoinhibited for chromatin binding—that can be stabilized by small molecule ligands encapsulated between two 53BP1 protomers. Such ligands are valuable research tools to study the function of 53BP1 and have the potential to facilitate the development of new drugs for cancer therapy.
format Online
Article
Text
id pubmed-10541411
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-105414112023-10-01 An autoinhibited state of 53BP1 revealed by small molecule antagonists and protein engineering Cui, Gaofeng Botuyan, Maria Victoria Drané, Pascal Hu, Qi Bragantini, Benoît Thompson, James R. Schuller, David J. Detappe, Alexandre Perfetti, Michael T. James, Lindsey I. Frye, Stephen V. Chowdhury, Dipanjan Mer, Georges Nat Commun Article The recruitment of 53BP1 to chromatin, mediated by its recognition of histone H4 dimethylated at lysine 20 (H4K20me2), is important for DNA double-strand break repair. Using a series of small molecule antagonists, we demonstrate a conformational equilibrium between an open and a pre-existing lowly populated closed state of 53BP1 in which the H4K20me2 binding surface is buried at the interface between two interacting 53BP1 molecules. In cells, these antagonists inhibit the chromatin recruitment of wild type 53BP1, but do not affect 53BP1 variants unable to access the closed conformation despite preservation of the H4K20me2 binding site. Thus, this inhibition operates by shifting the conformational equilibrium toward the closed state. Our work therefore identifies an auto-associated form of 53BP1—autoinhibited for chromatin binding—that can be stabilized by small molecule ligands encapsulated between two 53BP1 protomers. Such ligands are valuable research tools to study the function of 53BP1 and have the potential to facilitate the development of new drugs for cancer therapy. Nature Publishing Group UK 2023-09-29 /pmc/articles/PMC10541411/ /pubmed/37773238 http://dx.doi.org/10.1038/s41467-023-41821-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Cui, Gaofeng
Botuyan, Maria Victoria
Drané, Pascal
Hu, Qi
Bragantini, Benoît
Thompson, James R.
Schuller, David J.
Detappe, Alexandre
Perfetti, Michael T.
James, Lindsey I.
Frye, Stephen V.
Chowdhury, Dipanjan
Mer, Georges
An autoinhibited state of 53BP1 revealed by small molecule antagonists and protein engineering
title An autoinhibited state of 53BP1 revealed by small molecule antagonists and protein engineering
title_full An autoinhibited state of 53BP1 revealed by small molecule antagonists and protein engineering
title_fullStr An autoinhibited state of 53BP1 revealed by small molecule antagonists and protein engineering
title_full_unstemmed An autoinhibited state of 53BP1 revealed by small molecule antagonists and protein engineering
title_short An autoinhibited state of 53BP1 revealed by small molecule antagonists and protein engineering
title_sort autoinhibited state of 53bp1 revealed by small molecule antagonists and protein engineering
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10541411/
https://www.ncbi.nlm.nih.gov/pubmed/37773238
http://dx.doi.org/10.1038/s41467-023-41821-6
work_keys_str_mv AT cuigaofeng anautoinhibitedstateof53bp1revealedbysmallmoleculeantagonistsandproteinengineering
AT botuyanmariavictoria anautoinhibitedstateof53bp1revealedbysmallmoleculeantagonistsandproteinengineering
AT dranepascal anautoinhibitedstateof53bp1revealedbysmallmoleculeantagonistsandproteinengineering
AT huqi anautoinhibitedstateof53bp1revealedbysmallmoleculeantagonistsandproteinengineering
AT bragantinibenoit anautoinhibitedstateof53bp1revealedbysmallmoleculeantagonistsandproteinengineering
AT thompsonjamesr anautoinhibitedstateof53bp1revealedbysmallmoleculeantagonistsandproteinengineering
AT schullerdavidj anautoinhibitedstateof53bp1revealedbysmallmoleculeantagonistsandproteinengineering
AT detappealexandre anautoinhibitedstateof53bp1revealedbysmallmoleculeantagonistsandproteinengineering
AT perfettimichaelt anautoinhibitedstateof53bp1revealedbysmallmoleculeantagonistsandproteinengineering
AT jameslindseyi anautoinhibitedstateof53bp1revealedbysmallmoleculeantagonistsandproteinengineering
AT fryestephenv anautoinhibitedstateof53bp1revealedbysmallmoleculeantagonistsandproteinengineering
AT chowdhurydipanjan anautoinhibitedstateof53bp1revealedbysmallmoleculeantagonistsandproteinengineering
AT mergeorges anautoinhibitedstateof53bp1revealedbysmallmoleculeantagonistsandproteinengineering
AT cuigaofeng autoinhibitedstateof53bp1revealedbysmallmoleculeantagonistsandproteinengineering
AT botuyanmariavictoria autoinhibitedstateof53bp1revealedbysmallmoleculeantagonistsandproteinengineering
AT dranepascal autoinhibitedstateof53bp1revealedbysmallmoleculeantagonistsandproteinengineering
AT huqi autoinhibitedstateof53bp1revealedbysmallmoleculeantagonistsandproteinengineering
AT bragantinibenoit autoinhibitedstateof53bp1revealedbysmallmoleculeantagonistsandproteinengineering
AT thompsonjamesr autoinhibitedstateof53bp1revealedbysmallmoleculeantagonistsandproteinengineering
AT schullerdavidj autoinhibitedstateof53bp1revealedbysmallmoleculeantagonistsandproteinengineering
AT detappealexandre autoinhibitedstateof53bp1revealedbysmallmoleculeantagonistsandproteinengineering
AT perfettimichaelt autoinhibitedstateof53bp1revealedbysmallmoleculeantagonistsandproteinengineering
AT jameslindseyi autoinhibitedstateof53bp1revealedbysmallmoleculeantagonistsandproteinengineering
AT fryestephenv autoinhibitedstateof53bp1revealedbysmallmoleculeantagonistsandproteinengineering
AT chowdhurydipanjan autoinhibitedstateof53bp1revealedbysmallmoleculeantagonistsandproteinengineering
AT mergeorges autoinhibitedstateof53bp1revealedbysmallmoleculeantagonistsandproteinengineering